The link between SAA1 and Aβ is clearly explained by the results of a recent in vivo study, in which AD mouse models overexpressing SAA1 showed increased inflammation, documented by glial cell activation and increased release of cytokines, augmented amyloid aggregation, and worsened memory decline [77]. Here, SAA1 is linked to Alzheimer disease.